Gulliya K S, Sharma R, Liu H W, Arnold L, Matthews J L
Baylor Research Institute, Baylor University Medical Center, Dallas, TX 75226, USA.
Anticancer Drugs. 1995 Aug;6(4):545-52. doi: 10.1097/00001813-199508000-00007.
In previous studies we have reported that preactivated merocyanine 540 (pMC540) and its chemically synthesized isolates merocil and merodantoin mediate their preferential cytotoxicity towards certain types of malignant cells including human breast cancer cells in vitro and in vivo. The mechanism of cytotoxic action appears to be, in part, via initial interaction with topoisomerase II leading to apoptosis. To further build upon these findings we now show that pMC540 and merodantoin disrupt mitochondrial morphology and function in intact MCF-7 human breast cancer cells as seen by their causing the release of rhodamine 123 from prestained cells, a rapid reduction in ATP levels, inhibition of succinate dehydrogenase activity and oxygen consumption. These data suggest that mitochondria may also be an important target for the cytotoxic action of pMC540 and merodantoin mediated through disruption of the energy balance.
在之前的研究中我们报道过,预激活的部花青540(pMC540)及其化学合成的分离物美罗西和美罗丹宁在体外和体内对包括人乳腺癌细胞在内的某些类型的恶性细胞具有优先细胞毒性。细胞毒性作用机制似乎部分是通过与拓扑异构酶II的初始相互作用导致细胞凋亡。为了进一步基于这些发现,我们现在表明,pMC540和美罗丹宁破坏了完整的MCF-7人乳腺癌细胞中的线粒体形态和功能,这表现为它们导致罗丹明123从预染色细胞中释放、ATP水平迅速降低、琥珀酸脱氢酶活性受到抑制以及氧消耗减少。这些数据表明,线粒体也可能是pMC540和美罗丹宁通过破坏能量平衡介导的细胞毒性作用的重要靶点。